Early immunisation with hepatitis B vaccine: a five-year study. (Q52030056)

20 April 2018

title

Early immunisation with hepatitis B vaccine: a five-year study. (English)

1 reference

20 April 2018

1 reference

3

1 reference

20 April 2018

author name string

Belloni C

1

1 reference

20 April 2018

Pistorio A

2

1 reference

20 April 2018

Komakec J

4

1 reference

20 April 2018

Chirico G

5

1 reference

20 April 2018

Rovelli D

6

1 reference

20 April 2018

Gulminetti R

7

1 reference

20 April 2018

Comolli G

8

1 reference

20 April 2018

Orsolini P

9

1 reference

20 April 2018

Rondini G

10

1 reference

20 April 2018

language of work or name

English

0 references

publication date

1 January 2000

1 reference

20 April 2018

number of pages

5

1 reference

inferred from page(s)

published in

Vaccine

1 reference

20 April 2018

volume

18

1 reference

20 April 2018

issue

14

1 reference

20 April 2018

page(s)

1307-1311

1 reference

20 April 2018

A controlled clinical trial of the efficacy of the hepatitis B vaccine (Heptavax B): a final report

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900414-4

7 January 2021

Efficacy of a heat inactivated hepatitis B vaccine in male homosexuals: outcome of a placebo controlled double blind trial

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900414-4

7 January 2021

Production and immunological analysis of recombinant hepatitis B vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900414-4

7 January 2021

Vaccine induced immunologic memory for hepatitis B surface antigen: implications for policy on booster vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900414-4

7 January 2021

Anti-HBV neonatal immunization with recombinant vaccine. Part I. Critical appraisal for a long-lived antibody course

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900414-4

7 January 2021

Clinical experience with hepatitis B vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900414-4

7 January 2021

Four-year experience with a recombinant hepatitis B vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900414-4

7 January 2021

Quantification of hepatitis B vaccine-induced antibodies as a predictor of anti-HBs persistence.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900414-4

7 January 2021

Persistence of anti-HBs antibodies in health care personnel vaccinated with plasma-derived hepatitis B vaccine and response to recombinant DNA HB booster vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900414-4

7 January 2021

Immunogenicity of a recombinant Pre-S2-containing hepatitis B vaccine versus plasma-derived vaccine administered as a booster

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900414-4

7 January 2021

Recombinant DNA hepatitis B vaccination in teenagers: effect of a booster at 5 1/2 years

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900414-4

7 January 2021

Persistence of immunologic memory for twelve years in children given hepatitis B vaccine in infancy.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900414-4

7 January 2021

Ten-year follow-up study of neonatal hepatitis B immunization: are booster injections indicated?

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900414-4

7 January 2021

A 7-year follow-up of newborns vaccinated against hepatitis B

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900414-4

7 January 2021

Revaccination against hepatitis B virus of non-responding and low-responding infants immunised at birth. A parallel evaluation of rubella and tetanus vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900414-4

7 January 2021

Factors influencing the immune response to hepatitis B vaccine, booster dose guidelines, and vaccine protocol recommendations

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900414-4

7 January 2021

Scheduling of revaccination against hepatitis B virus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900414-4

7 January 2021

Ten-year neonatal hepatitis B vaccination program, The Netherlands, 1982-1992: protective efficacy and long-term immunogenicity

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900414-4

7 January 2021

Vaccination against hepatitis B and protection against chronic viral carriage in The Gambia

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900414-4

7 January 2021

Comparative study of the immunogenicity and safety of two dosing schedules of Engerix-B hepatitis B vaccine in neonates

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900414-4

7 January 2021

Antibody response to accelerated immunisation with diphtheria, tetanus, pertussis vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900414-4

7 January 2021

Protection provided by hepatitis B vaccine in a Yupik Eskimo population--results of a 10-year study

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900414-4

7 January 2021

10.1016/S0264-410X(99)00414-4

Identifiers

DOI

1 reference

20 April 2018

PubMed ID

10618526

1 reference

20 April 2018